When it comes to living with asthma, having access to the right information is essential. Use the following helpful resources to help you educate yourself and others about asthma.
- Asthma emergency card
- A helpful resource where you can keep important information.
- Asthma symptoms and attacks
- Learn to recognize some common asthma symptoms.
- Asthma education videos
- Watch Dr. Craig Jones discussing asthma with patients.
- Asthma control checklist
- Find out if your asthma is really under control.
- Where to learn more
- Find links to asthma information, resources, and helpful tips.
- Things people say about their asthma
- See answers to common questions people have about asthma.
[PDF 0.99 MB, 6 pages]
SINGULAIR is a prescription medicine approved to help control asthma in adults and children as young as 12 months and to help relieve the symptoms of indoor and outdoor allergies (outdoor allergies in adults and children as young as 2 years, and indoor allergies in adults and children as young as 6 months).
IMPORTANT SAFETY INFORMATION
SINGULAIR will NOT replace fast-acting inhalers for sudden symptoms. You should still have rescue medication available and continue to take your other asthma medications unless your doctor tells you to stop. For asthma, SINGULAIR should be taken once a day, in the evening as prescribed, whether or not you have asthma symptoms. If your symptoms get worse or you need to increase the use of your rescue inhaler, call your doctor at once.
Side effects are generally mild and vary by age, and may include headache, ear infection, sore throat, and upper respiratory infection. Side effects generally did not stop patients from taking SINGULAIR. Check with your doctor if you're pregnant or nursing. SINGULAIR should be taken once a day, as prescribed. SINGULAIR is available by prescription only.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional safety information, please see Patient Product Information.